News Summary:
BENGALURU, India, Dec. 6, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) inaugurated its new Global Capability Center (GCC), a strategic investment to accelerate technology adoption, innovation, digital transformation, and business efficiencies through a concentrated hub of talent that will operate across the Waters global enterprise.
The Waters India GCC is in a newly built facility in Bengaluru's RMZ Ecoworld technology park, a WELL and LEED Platinum-certified campus that exemplifies a commitment to a healthy and eco-conscious workspace. The new US$16M (INR ₹1.3Bn) workspace will employ 300+ for roles that were formerly outsourced to various outside service providers and will transform into an India-based global hub designed to in-source talent, accelerate technology adoption, and drive technological innovation.
"India continues to be one of our fastest growing markets and a key location for the talent that we need to drive global customer success and innovation forward," said Dr. Udit Batra, President and CEO of Waters Corporation. "The Waters India GCC is an integrated extension of our global team, serving as a center of excellence across areas such as software engineering, technology and product development. This is an exciting day for Waters as the future holds many possibilities."
"Opening the Waters GCC is a significant milestone for our team in India. We chose Bengaluru because of the availability and depth of talent, the friendly business environment, and its close proximity to our customers," said T Anilkumar, General Manager of Waters India Pvt. Ltd. "Our GCC in Bengaluru will allow us to access and develop exceptional talent within Waters to accelerate our technological capabilities, operational excellence and productivity in support of our customers in India and around the world."
For more than 60 years Waters has focused on improving human health and wellbeing around the world as a leading developer of scientific instruments, software, and chemistries. In 1988, Waters became one of the first analytical instruments companies to start operations in India and has since grown to nine sites and over 430 employees, serving customers across more than 2,300 laboratories in India. Waters technologies and services help customers and innovators around the world ensure the safety of medicines and vaccines, the purity of food and water, and the quality and sustainability of products that millions of people use every day.
Additional Resources
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for over 60 years. With approximately 8,000 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.
Contact:
Padmini Satish
Marketing Communications Lead
Waters India Pvt. Ltd.
+91 80 49292200-3
This email address is being protected from spambots. You need JavaScript enabled to view it.
Kevin Kempskie
Senior Director, Public Relations
Waters Corporation
+1.508.482.2814
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$357.77 |
Daily Change: | 13.06 3.79 |
Daily Volume: | 660,932 |
Market Cap: | US$21.240B |
November 07, 2024 November 01, 2024 October 10, 2024 October 08, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB